Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREWith the ability to understand and view vast amounts of non-identified patient data, in real-time, the IQVIA Brand Analytics Platform is an essential commercial planning component that will drive successful business outcomes for any life science’s company, and is fully backed by, factual, transparent information, with demonstrated, provable results for accurate, reliable, and repeatable answers to the most important business questions.
LEARN HOW TO GET IMMEDIATE ACCESS AND COMPLETE VISIBILITY INTO YOUR CRITICAL PATIENT AND MARKET INSIGHTS
Powered by IQVIA’s Analytics Engine, featuring best-in-class data and analytics methodologies, IQVIA’s Brand Analytics Platform is a self-service, intuitive technology that provides companies with immediate and seamless access to critical information, powerful analytics, and dynamic visualization capabilities that empower commercial teams to quickly identify market insights and easily view, manipulate, and export the data and visuals they want, when their teams need it the most.
Track and size the number of treated patients based on LRx pharmacy drugs or Dx based drugs/procedures.
Profile and size the number of diagnosed patients in the U.S. and segment by treated vs. untreated for a specific patient population with the ability to segment the market
Gain a better understanding of factors influencing product compliance and persistence.
The Data Science Workbench empowers data scientists by allowing them to accurately answer critical business questions and predict market trends and behaviors so that organizations can make the best decisions for their commercial products.
With built in flexibility to create and manage data structures using a variety of applications, including Python, SQL, or Scala, users can quickly and easily build and rebuild scalable data models with consistent results and the confidence knowing that their models are powered by an exceptional data repository — the IQVIA Analytics Engine.
The Data Science Workbench is completely compatible with a wide variety of dashboard visualization tools, including Power BI, Tableau, Qlik, ThoughtSpot, HEX, and more, enabling seamless integration into your preferred environment.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Navigate complex regulatory requirements with expert insights and bring transparency, efficiency and predictability to your regulatory affairs strategy.
Strengthen your portfolio by making more informed decisions and fewer assumptions, and prepare for the impact of new research discoveries and events.
